Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles R Nolan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Pain and Symptom Management|September 2, 2022
A Gift Twice-Given is Truly ReceivedCharles R Nolan
Kidney International. Supplement|June 16, 2005
Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelinesCharles R Nolan
Journal of the American Society of Nephrology : JASN|October 28, 2005
Strategies for improving long-term survival in patients with ESRDCharles R Nolan
Kidney International. Supplement|May 11, 2005
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysisCharles R Nolan, Wajeh Y Qunibi
Current Opinion in Nephrology and Hypertension|June 20, 2003
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patientsCharles R Nolan, Wajeh Y Qunibi
Kidney International. Supplement|August 7, 2004
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE studyWajeh Y Qunibi, Charles R Nolan
Kidney International|December 11, 2002
Calcium on trial: beyond a reasonable doubt?Charles R Nolan, Wajeh Y Quinibi
Kidney International|March 23, 2005
Economic impact of sevelamer in patients with ESRDWajeh Y Qunibi, Charles R Nolan
Kidney International. Supplement|August 7, 2004
Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implicationsBarton Brezina, Wajeh Y Qunibi, Charles R Nolan
Kidney International|June 16, 2005
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetesWajeh Y Qunibi, Fadi Abouzahr, Mohammad R Mizani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Pain and Symptom Management|September 2, 2022
A Gift Twice-Given is Truly ReceivedCharles R Nolan
Kidney International. Supplement|June 16, 2005
Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelinesCharles R Nolan
Journal of the American Society of Nephrology : JASN|October 28, 2005
Strategies for improving long-term survival in patients with ESRDCharles R Nolan
Kidney International. Supplement|May 11, 2005
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysisCharles R Nolan, Wajeh Y Qunibi
Current Opinion in Nephrology and Hypertension|June 20, 2003
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patientsCharles R Nolan, Wajeh Y Qunibi
Kidney International. Supplement|August 7, 2004
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE studyWajeh Y Qunibi, Charles R Nolan
Kidney International|December 11, 2002
Calcium on trial: beyond a reasonable doubt?Charles R Nolan, Wajeh Y Quinibi
Kidney International|March 23, 2005
Economic impact of sevelamer in patients with ESRDWajeh Y Qunibi, Charles R Nolan
Kidney International. Supplement|August 7, 2004
Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implicationsBarton Brezina, Wajeh Y Qunibi, Charles R Nolan
Kidney International|June 16, 2005
Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetesWajeh Y Qunibi, Fadi Abouzahr, Mohammad R Mizani, et al.
Pageof 2